BioMedical Genomics Unit (BMGU)

The mandate of Biomedical Genomics Unit (BMGU) is to accelerate basic & translational research by empowering clinicians to carry out independent research and training. Establishment of BMGU was guided by the commitment of NIBMG to ensure a proximate and fruitful research engagement between clinicians and basic scientists.

Research in BMGU encompasses a wide variety of genotype-phenotype correlations, gene-environment interactions and effective utilization of genome-scale data in clinical care. BMGU intends to enable clinician researchers to generate basic genomic evidence for identified and defined disease/health phenotypes to facilitate genome-based solutions. The Unit also aims to promote genomic research capacity building by training medical students, researchers and professionals through workshops, continuing education and other training programs.


  • Currently, several faculty members of NIBMG have ongoing research collaborations that leverage BMGU platform.
  • Dr. Saroj Kant Mohapatra has initiated a collaborative study with the Department of Pulmonology, IPGME&R to dissect the molecular underpinning of COVID-19 immunothrombosis.
  • Dr. Srikanta Goswami collaborates with the School of Digestive and Liver Diseases, IPGME&R on acute/ chronic pancreatitis and pancreatic cancer.
  • Dr. Souvik Mukherjee collaborates with Dept. of Dermatology in IPGME&R, CNMC, Medical College, MR Bangur Hospital and Dept. of Endocrinology and Metabolism of IPGME&R in the area of host-microbiome interactions in chronic autoimmune as well as lifestyle disorders in humans.
  • Dr. Bhaswati Pandit collaborates with the Department of Rheumatology, IPGME&R, Kolkata focusing on Myocbacterial and other immunodeficiency diseases.
  • Dr. Moulinath Acharya is collaborating with the Department of Neonatology, IPGME&R, Kolkata in the field of genomics of non-syndromic hearing loss.
  • Dr. Priyadarshi Basu is collaborating with Prof. Abhijit Chowdhury and Dr. Kausik Das of IPGME&R in the field of genomics, epigenomics and transcriptomics of non-alcoholic fatty liver disease.